PREDNISONE, BMS-986365, ENZALUTAMIDE, ABIRATERONE, DOCETAXEL, PREDNISOLONE, ABIRATERONE, ENZALUTAMIDE
CA071-1000
Phase 3 small_molecule active
Quick answer
PREDNISONE, BMS-986365, ENZALUTAMIDE, ABIRATERONE, DOCETAXEL, PREDNISOLONE, ABIRATERONE, ENZALUTAMIDE for Metastatic Castration-resistant Prostate Cancer (mCRPC) is a Phase 3 program (small_molecule) at Celgene Europe Limited with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Celgene Europe Limited
- Indication
- Metastatic Castration-resistant Prostate Cancer (mCRPC)
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active